Viral Safety: The AFSSAPS Speaks Out About the Regulatory Environment
Add bookmark
Viral Safety: The AFSSAPS Speaks Out About the Regulatory Environment
Add bookmark
Contaminations in biological products in 2009 and the porcine circovirus contamination of GSK’s Rotarix vaccine in March of this year has highlighted the issue of viral safety in biologics more than ever before. Marc Martin, Viral Safety Assessor at AFSSAPS, joins Helen Winsor from Pharma IQ, to discuss the evolution of the requirements for viral clearance. In this interview, he gives a general overview of the regulatory environment and talks about where we are up to in the move...
Tags:
Marc Martin
viral safety
AFSSAPS
viral safety assessor
viral safety biologics
international viral safety regulations
viral safety regulations
ICH and CPMP viral safety requirements
global regulatory environment
viral clearance steps
viral clearance
